{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:35:12Z","timestamp":1772854512288,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ackdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1053\/j.ackd.2014.10.003","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T01:16:35Z","timestamp":1429578995000},"page":"196-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Outcomes of Drug-Based and Surgical Treatments for Primary Aldosteronism"],"prefix":"10.1053","volume":"22","author":[{"given":"Olivier","family":"Steichen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelien","family":"Lorthioir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Zinzindohoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Fran\u00e7ois","family":"Plouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2014.10.003_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1172-5-9","article-title":"Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism","volume":"5","author":"Amar","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1053\/j.ackd.2014.10.003_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1681\/ASN.2010080827","article-title":"The WNK kinase network regulating sodium, potassium, and blood pressure","volume":"22","author":"Hoorn","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2014.10.003_bib3","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2891","article-title":"Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors","volume":"18","author":"McCurley","year":"2012","journal-title":"Nat Med"},{"issue":"9","key":"10.1053\/j.ackd.2014.10.003_bib4","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1210\/jc.2011-0354","article-title":"Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study","volume":"96","author":"Pimenta","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jhh.2012.27","article-title":"Salt, aldosterone and hypertension","volume":"27","author":"Pimenta","year":"2013","journal-title":"J Hum Hypertens"},{"issue":"12","key":"10.1053\/j.ackd.2014.10.003_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/1440-1681.12145","article-title":"Aldosterone, organ damage and dietary salt","volume":"40","author":"Catena","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"10","key":"10.1053\/j.ackd.2014.10.003_bib7","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/bjs.4738","article-title":"Laparoscopic adrenalectomy","volume":"91","author":"Assalia","year":"2004","journal-title":"Br J Surg"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00464-004-8269-3","article-title":"Minimal access adrenal surgery","volume":"20","author":"Brunt","year":"2006","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.juro.2010.03.052","article-title":"Partial adrenalectomy: underused first line therapy for small adrenal tumors","volume":"184","author":"Kaye","year":"2010","journal-title":"J Urol"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.juro.2010.12.051","article-title":"Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma","volume":"185","author":"Fu","year":"2011","journal-title":"J Urol"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0031-1299681","article-title":"Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review","volume":"44","author":"Steichen","year":"2012","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00261-013-9995-6","article-title":"Percutaneous ablation of functioning adrenal adenoma: a report on 11 cases and a review of the literature","volume":"38","author":"Nunes","year":"2013","journal-title":"Abdom Imaging"},{"issue":"12","key":"10.1053\/j.ackd.2014.10.003_bib13","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/bjs.8921","article-title":"Systematic review and meta-analysis of retroperitoneoscopic versus laparoscopic adrenalectomy","volume":"99","author":"Constantinides","year":"2012","journal-title":"Br J Surg"},{"key":"10.1053\/j.ackd.2014.10.003_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2490-10-19","article-title":"Initial experience of transumbilical laparoendoscopic single-site surgery of partial adrenalectomy in patient with aldosterone-producing adenoma","volume":"10","author":"Yuge","year":"2010","journal-title":"BMC Urol"},{"issue":"2","key":"10.1053\/j.ackd.2014.10.003_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.eururo.2013.05.034","article-title":"EAU guidelines on robotic and single-site surgery in urology","volume":"64","author":"Merseburger","year":"2013","journal-title":"Eur Urol"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MOU.0b013e32831b446c","article-title":"The role of robotics for adrenal pathology","volume":"19","author":"Hyams","year":"2009","journal-title":"Curr Opin Urol"},{"issue":"6","key":"10.1053\/j.ackd.2014.10.003_bib17","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.eururo.2013.09.021","article-title":"Robotic versus laparoscopic adrenalectomy: a systematic review and meta-analysis","volume":"65","author":"Brandao","year":"2014","journal-title":"Eur Urol"},{"issue":"6","key":"10.1053\/j.ackd.2014.10.003_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.surg.2006.07.039","article-title":"Posterior retroperitoneoscopic adrenalectomy\u2013results of 560 procedures in 520 patients","volume":"140","author":"Walz","year":"2006","journal-title":"Surgery"},{"issue":"12","key":"10.1053\/j.ackd.2014.10.003_bib19","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00464-002-8878-7","article-title":"Laparoscopic transperitoneal adrenalectomy","volume":"17","author":"O'Boyle","year":"2003","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00464-008-9947-3","article-title":"Previously unreported high-grade complications of adrenalectomy","volume":"23","author":"Tessier","year":"2009","journal-title":"Surg Endosc"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0022-5347(05)67790-7","article-title":"Outpatient adrenalectomy","volume":"163","author":"Gill","year":"2000","journal-title":"J Urol"},{"issue":"6","key":"10.1053\/j.ackd.2014.10.003_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s004640090021","article-title":"Outpatient laparoscopic adrenalectomy in patients with Conn's syndrome","volume":"15","author":"Edwin","year":"2001","journal-title":"Surg Endosc"},{"issue":"8","key":"10.1053\/j.ackd.2014.10.003_bib23","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1007\/s00464-011-1588-2","article-title":"Outpatient laparoscopic adrenalectomy: a new step ahead","volume":"25","author":"Ram\u00edrez-Plaza","year":"2011","journal-title":"Surg Endosc"},{"issue":"11","key":"10.1053\/j.ackd.2014.10.003_bib24","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2012-2234","article-title":"Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy","volume":"97","author":"Fischer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.ackd.2014.10.003_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2013.05.017","article-title":"Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma","volume":"424","author":"Chiang","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1053\/j.ackd.2014.10.003_bib26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s002689900552","article-title":"Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production","volume":"22","author":"Rutherford","year":"1998","journal-title":"World J Surg"},{"issue":"10","key":"10.1053\/j.ackd.2014.10.003_bib27","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1097\/HJH.0000000000000284","article-title":"Oxidative stress in patients affected by primary aldosteronism","volume":"32","author":"Petramala","year":"2014","journal-title":"J Hypertens"},{"issue":"2","key":"10.1053\/j.ackd.2014.10.003_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/HYPERTENSIONAHA.109.141531","article-title":"Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study","volume":"55","author":"Gaddam","year":"2010","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1470320310376424","article-title":"Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy","volume":"12","author":"Lin","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"8","key":"10.1053\/j.ackd.2014.10.003_bib32","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/HJH.0b013e3283550f93","article-title":"Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism","volume":"30","author":"Lin","year":"2012","journal-title":"J Hypertens"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2011.12.003","article-title":"Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma","volume":"221","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"issue":"10","key":"10.1053\/j.ackd.2014.10.003_bib35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ajh.2008.243","article-title":"Adrenalectomy improves arterial stiffness in primary aldosteronism","volume":"21","author":"Strauch","year":"2008","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1053\/j.ackd.2014.10.003_bib37","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1053\/j.ackd.2014.10.003_bib38","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1172\/JCI103392","article-title":"Renal function in primary aldosteronism","volume":"35","author":"Dustan","year":"1956","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.ackd.2014.10.003_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1470320310391331","article-title":"Relative kidney hyperfiltration in primary aldosteronism: a meta-analysis","volume":"12","author":"Kuo","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"4","key":"10.1053\/j.ackd.2014.10.003_bib40","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","article-title":"Intrarenal hemodynamics in primary aldosteronism before and after treatment","volume":"94","author":"Sechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.ackd.2014.10.003_bib41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"issue":"10","key":"10.1053\/j.ackd.2014.10.003_bib42","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A clinical prediction score to diagnose unilateral primary aldosteronism","volume":"97","author":"K\u00fcpers","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib43","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"22","key":"10.1053\/j.ackd.2014.10.003_bib44","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ackd.2014.10.003_bib45","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2215\/CJN.00050107","article-title":"Relationships of plasma renin levels with renal function in patients with primary aldosteronism","volume":"2","author":"Catena","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib46","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.ackd.2014.10.003_bib47","first-page":"S639","article-title":"What is the clinical significance of masked chronic kidney disease in patients with primary aldosteronism?","volume":"57","author":"Takahashi","year":"2010","journal-title":"Endocr J"},{"key":"10.1053\/j.ackd.2014.10.003_bib48","first-page":"S646","article-title":"Renal function deteriorates regardless of the type of treatments in primary aldosteronism","volume":"57","author":"Tsuiki","year":"2010","journal-title":"Endocr J"},{"issue":"10","key":"10.1053\/j.ackd.2014.10.003_bib49","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/jhh.2010.102","article-title":"Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma","volume":"25","author":"Pimenta","year":"2011","journal-title":"J Hum Hypertens"},{"issue":"9","key":"10.1053\/j.ackd.2014.10.003_bib50","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment","volume":"29","author":"Wu","year":"2011","journal-title":"J Hypertens"},{"issue":"15-16","key":"10.1053\/j.ackd.2014.10.003_bib51","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cca.2011.02.018","article-title":"Kidney impairment in primary aldosteronism","volume":"412","author":"Wu","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1053\/j.ackd.2014.10.003_bib52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/iju.12029","article-title":"Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy","volume":"20","author":"Utsumi","year":"2013","journal-title":"Int J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-12-0631","article-title":"Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism","volume":"168","author":"Fourkiotis","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.12497","article-title":"Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism","volume":"81","author":"Tanase-Nakao","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib55","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2011.03.029","article-title":"Aldosterone-induced fibrosis in the kidney: questions and controversies","volume":"58","author":"Brem","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ackd.2014.10.003_bib57","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"issue":"4","key":"10.1053\/j.ackd.2014.10.003_bib59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study","volume":"53","author":"Matrozova","year":"2009","journal-title":"Hypertension"},{"issue":"10","key":"10.1053\/j.ackd.2014.10.003_bib60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/jhh.2010.65","article-title":"The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism","volume":"24","author":"Soml\u00f3ov\u00e1","year":"2010","journal-title":"J Hum Hypertens"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib61","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status\u00a0following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.ackd.2014.10.003_bib62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.HYP.12.2.192","article-title":"Dietary sodium change in primary aldosteronism. Atrial natriuretic factor, hormonal, and vascular responses","volume":"12","author":"Pedrinelli","year":"1988","journal-title":"Hypertension"},{"issue":"12 pt 1","key":"10.1053\/j.ackd.2014.10.003_bib63","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1097\/00004872-199816120-00006","article-title":"Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy","volume":"16","author":"Uzu","year":"1998","journal-title":"J Hypertens"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib64","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1291\/hypres.25.737","article-title":"Dietary sodium restriction restores nocturnal reduction of blood pressure in patients with primary aldosteronism","volume":"25","author":"Takakuwa","year":"2002","journal-title":"Hypertens Res"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.48.3.491","article-title":"Spironolactone as a nonspecific treatment for primary aldosteronism","volume":"48","author":"Bravo","year":"1973","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"J Hypertens"},{"issue":"10","key":"10.1053\/j.ackd.2014.10.003_bib67","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1053\/j.ackd.2014.10.003_bib68","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","article-title":"Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism","volume":"9","author":"Karagiannis","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib69","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"issue":"4","key":"10.1053\/j.ackd.2014.10.003_bib70","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/clpt.1980.75","article-title":"Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients","volume":"27","author":"Ramsay","year":"1980","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1053\/j.ackd.2014.10.003_bib71","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.1981.155","article-title":"Triamterene-thiazide combination: alternative therapy for primary aldosteronism","volume":"30","author":"Ganguly","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1053\/j.ackd.2014.10.003_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2125.1982.tb01970.x","article-title":"Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia","volume":"14","author":"Jackson","year":"1982","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib73","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","article-title":"A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity","volume":"51","author":"Dietz","year":"2008","journal-title":"Hypertension"},{"key":"10.1053\/j.ackd.2014.10.003_bib74","doi-asserted-by":"crossref","first-page":"519467","DOI":"10.1155\/2012\/519467","article-title":"Suppression of aldosterone synthesis and secretion by Ca(2+) channel antagonists","volume":"2012","author":"Ikeda","year":"2012","journal-title":"Int J Endocrinol"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib75","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/jcem-60-5-896","article-title":"Therapeutic effect of calcium channel blockade in primary aldosteronism","volume":"60","author":"Nadler","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1345\/aph.1H456","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion","volume":"41","author":"Bubbar","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1440-1681.1987.tb00371.x","article-title":"Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis","volume":"14","author":"Gordon","year":"1987","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1358\/mf.2001.23.3.627950","article-title":"Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension","volume":"23","author":"Zacharieva","year":"2001","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"31","key":"10.1053\/j.ackd.2014.10.003_bib79","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","article-title":"Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial","volume":"34","author":"Pitt","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FJC.0000000000000091","article-title":"Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury","volume":"64","author":"Kolkhof","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib81","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/HYPERTENSIONAHA.110.157271","article-title":"Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism","volume":"56","author":"Amar","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib82","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/HJH.0b013e32835d6d49","article-title":"Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism","volume":"31","author":"Amar","year":"2013","journal-title":"J Hypertens"},{"issue":"2","key":"10.1053\/j.ackd.2014.10.003_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","article-title":"Medical management of aldosterone-producing adenomas","volume":"131","author":"Ghose","year":"1999","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0002-8703(78)90132-1","article-title":"The treatment of low-renin (\u201cprimary\u201d) hyperaldosteronism","volume":"96","author":"Ferriss","year":"1978","journal-title":"Am Heart J"},{"issue":"7","key":"10.1053\/j.ackd.2014.10.003_bib85","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/ndt\/gfs587","article-title":"Regression of left ventricular hypertrophy in patients with primary aldosteronism\/low-renin hypertension on low-dose spironolactone","volume":"28","author":"Ori","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ackd.2014.10.003_bib86","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib87","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(05)64023-2","article-title":"Adrenocortical carcinoma: diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J Urol"},{"issue":"9","key":"10.1053\/j.ackd.2014.10.003_bib88","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1 pt 2","key":"10.1053\/j.ackd.2014.10.003_bib89","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"issue":"suppl 1","key":"10.1053\/j.ackd.2014.10.003_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S1.1","article-title":"The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1053\/j.ackd.2014.10.003_bib91","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"issue":"4","key":"10.1053\/j.ackd.2014.10.003_bib92","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/HJH.0b013e328350225d","article-title":"Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study","volume":"30","author":"Van der Linden","year":"2012","journal-title":"J Hypertens"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib93","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ackd.2014.10.003_bib94","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ackd.2014.10.003_bib95","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","article-title":"The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma","volume":"247","author":"Zarnegar","year":"2008","journal-title":"Ann Surg"},{"issue":"12","key":"10.1053\/j.ackd.2014.10.003_bib96","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1365-2168.2002.02261.x","article-title":"Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism","volume":"89","author":"Sywak","year":"2002","journal-title":"Br J Surg"},{"issue":"6","key":"10.1053\/j.ackd.2014.10.003_bib97","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.surg.2010.09.012","article-title":"The management of aldosterone-producing adrenal adenomas\u2014does adrenalectomy increase costs?","volume":"148","author":"Reimel","year":"2010","journal-title":"Surgery"},{"issue":"7","key":"10.1053\/j.ackd.2014.10.003_bib98","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib99","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jvir.2013.01.496","article-title":"Adrenal venous sampling for primary hyperaldosteronism in patients with concurrent chronic kidney disease","volume":"24","author":"Burshteyn","year":"2013","journal-title":"J Vasc Interv Radiol"},{"issue":"5 suppl 1","key":"10.1053\/j.ackd.2014.10.003_bib100","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ackd.2014.10.003_bib101","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2010.30","article-title":"Aldosterone: effects on the kidney and cardiovascular system","volume":"6","author":"Briet","year":"2010","journal-title":"Nat Rev Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559514001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559514001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T09:22:53Z","timestamp":1537694573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559514001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1548559514001670"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2014.10.003","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Drug-Based and Surgical Treatments for Primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2014.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}